Displacement of the binding of 5-HT1A receptor ligands to pre- and postsynaptic receptors by (-)pindolol.: A comparative study in rodent, primate and human brain

被引:0
作者
Raurich, A [1 ]
Mengod, G [1 ]
Artigas, F [1 ]
Cortés, R [1 ]
机构
[1] CSIC, IDIBAPS, Inst Invest Biomed Barcelona, Dept Neurochem,IIBB, Barcelona 08036, Spain
关键词
5-hydroxytryptamine; antidepressant drugs; dorsal raphe nucleus; hippocampus; receptor autoradiography;
D O I
10.1002/(SICI)1098-2396(199910)34:1<68::AID-SYN8>3.3.CO;2-Q
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Using receptor autoradiography we examined the displacement of the binding of [H-3]8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) and [H-3][N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridyl)cyclohexanecarboxamide . 3HCl] (WAY 100635) to 5-HT1A receptors by (-)pindolol in the brain of four different species, rat, guinea pig, monkey and human. (-)pindolol completely displaced the binding of both tritiated ligands at 10(-6) M in all species and regions examined. The affinity of (-)pindolol for presynaptic 5-HT1A receptors in the dorsal raphe nucleus was similar to that observed in postsynaptic locations, such as hippocampus (areas CA1, CA3 and dentate gyrus) or entorhinal cortex. Affinity values (K-i) were in the range 3.8 - 15.9 nM for [H-3]8-OH-DPAT and 5.8 - 22.3 nM for [H-3]WAY 100635. In human brain, the K-i values using [H-3]8-OH-DPAT as ligand were 10.8 nM in the dorsal raphe nucleus and 6.5 - 13.5 in postsynaptic sites. The present data do not support the hypothesis that (-)pindolol may displace 5-HT1A ligands preferentially from presynaptic 5-HT1A receptors in the dorsal raphe nucleus, as suggested by electrophysiological evidence. The affinity of (-)pindolol for human 5-HT1A receptors is below the mean plasma concentration attained in depressed patients treated with a combination of fluoxetine and pindolol, which indirectly supports an action of pindolol at 5-HT1A receptors in these patients. (C) 1999 Wiley-Liss, Inc.
引用
收藏
页码:68 / 76
页数:9
相关论文
共 64 条
  • [1] ADELL A, 1991, N-S ARCH PHARMACOL, V343, P237
  • [2] THE EFFICACY OF SELECTIVE SEROTONIN REUPTAKE INHIBITORS IN DEPRESSION - A METAANALYSIS OF STUDIES AGAINST TRICYCLIC ANTIDEPRESSANTS
    ANDERSON, IM
    TOMENSON, BM
    [J]. JOURNAL OF PSYCHOPHARMACOLOGY, 1994, 8 (04) : 238 - 249
  • [3] PHARMACOLOGICALLY DISTINCT ACTIONS OF SEROTONIN ON SINGLE PYRAMIDAL NEURONS OF THE RAT HIPPOCAMPUS RECORDED INVITRO
    ANDRADE, R
    NICOLL, RA
    [J]. JOURNAL OF PHYSIOLOGY-LONDON, 1987, 394 : 99 - 124
  • [4] ARBORELIUS L, 1995, N-S ARCH PHARMACOL, V352, P157
  • [5] The 5-HT1A receptor antagonist (S)-UH-301 augments the increase in extracellular concentrations of 5-HT in the frontal cortex produced by both acute and chronic treatment with citalopram
    Arborelius, L
    Nomikos, GG
    Hertel, P
    Salmi, P
    Grillner, P
    Hook, BB
    Hacksell, U
    Svensson, TH
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1996, 353 (06) : 630 - 640
  • [6] Acceleration of the effect of selected antidepressant drugs in major depression by 5-HT1A antagonists
    Artigas, F
    Romero, L
    deMontigny, C
    Blier, P
    [J]. TRENDS IN NEUROSCIENCES, 1996, 19 (09) : 378 - 383
  • [7] ARTIGAS F, 1994, ARCH GEN PSYCHIAT, V51, P248
  • [8] 5-HT AND ANTIDEPRESSANTS - NEW VIEWS FROM MICRODIALYSIS STUDIES
    ARTIGAS, F
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 1993, 14 (07) : 262 - 262
  • [9] ARTIGAS F, 1997, 36 ANN M AM COLL NEU, P37
  • [10] 8-HYDROXY-2-(DI-NORMAL-PROPYLAMINO)TETRALIN, A NEW CENTRALLY ACTING 5-HYDROXYTRYPTAMINE RECEPTOR AGONIST
    ARVIDSSON, LE
    HACKSELL, U
    NILSSON, JLG
    HJORTH, S
    CARLSSON, A
    LINDBERG, P
    SANCHEZ, D
    WIKSTROM, H
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1981, 24 (08) : 921 - 923